Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Bullish Case for Aurora Cannabis Is so Close Yet so Far Away

By Chris Markoch, InvestorPlace Contributor

The long-term outlook for the cannabis market gives ACB stock an appealing bullish case, but that does nothing for investors in the near term.

The Reward of Buying Carnival Shares Isn’t Worth the Risk

By Chris Markoch, InvestorPlace Contributor

Carnival is taking its first steps toward normalcy, and CCL stock may have calmer waters ahead. Still, remaining risks may curtail growth.

CureVac Stock Is Just Another Part of a Bigger Story

By Chris Markoch, InvestorPlace Contributor

With its Covid-19 vaccine candidate, CureVac stock soared after its IPO in August. But as Operation Warp Speed wraps up, investors may wonder if there's anything else.

The 5 Best Cheap Stocks to Buy for Contrarian Investors

By Chris Markoch, InvestorPlace Contributor

Investors are looking for value wherever they can find it. One of the tried-and-true ways to find cheap stocks to buy is to look for contrarian plays.

The Tech Wreck Is Just What Advanced Micro Devices Needed

By Chris Markoch, InvestorPlace Contributor

Advanced Micro Devices is one of the best performing stocks of 2020. That's why investors should celebrate the dip in AMD stock price as a great buying opportunity.

This Is No Time to Lack Conviction on Novavax

By Chris Markoch, InvestorPlace Contributor

NVAX stock is up over 2,000% since March. But as the clinical trials advance, investors need to decide if they're in or out.

Vroom Stock Will Look Better From a Distance

By Chris Markoch, InvestorPlace Contributor

There are many reasons to fall in love with Vroom stock. But with the company signaling that revenue is slowing, now is a time to just be friends.

The Bullish Case for Nokia Stock Moves to Europe

By Chris Markoch, InvestorPlace Contributor

Nokia stock is up over 100% since March. And while the 5G buildout in the U.S. is making analysts bullish, Europe presents other challenges.

Should You Invest in Exxon Mobil Stock After It’s Been Cancelled?

By Chris Markoch, InvestorPlace Contributor

Exxon Mobil stock continues to slide after being removed from the Dow. Climate change activists claim credit, but this is really just about performance.

4 Hydrogen Stocks That Are Ready to Charge Your Portfolio

By Chris Markoch, InvestorPlace Contributor

As demand for oil remains low and investors look for new innovations, these four hydrogen stocks deserve some time in the spotlight.

Load More